martindale.com
Legal Library
|
Sort by:  | Tyco International, Ltd. Pays More Than $26 Million to Settle FCPA Allegations: Improper Payments Made to Foreign Officials in Over a Dozen Countries, Including China
Eric Carlson, Shaoyu Chen, Timothy P. Stratford; Covington & Burling LLP;
Legal Alert/Article October 2, 2012, previously published on September 25, 2012 On September 24, 2012, Tyco International Ltd. (“Tyco”) agreed to pay more than $26 million to settle allegations that its subsidiaries violated the Foreign Corrupt Practices Act (“FCPA”) by making improper payments to government officials in over a dozen countries across...
| | SFDA Issues Proposed Regulations for the Administration of Inspections of Foreign Drug Manufacturers
Shaoyu Chen, Scott Cunningham, Jason Ma; Covington & Burling LLP;
Legal Alert/Article September 13, 2012, previously published on September 2012 On August 20, 2012, China’s State Food and Drug Administration ("SFDA") released for public comment the proposed Measures for the Administration of Inspections of Foreign Drug Manufacturers ("Proposed Measures"). The comment period for the Proposed Measures will end on...
| | Pfizer Inc. & Subsidiaries Pay $60.2 Million to Settle FCPA Allegations
Eric Carlson, Shaoyu Chen, Timothy P. Stratford; Covington & Burling LLP;
Legal Alert/Article August 22, 2012, previously published on August 13, 2012 On August 7, 2012, global pharmaceutical giant Pfizer Inc. (“Pfizer”) and two subsidiaries agreed to pay a total of $60.2 million to settle charges by the US Department of Justice (“DOJ”) and US Securities and Exchange Commission (“SEC”) that employees and...
| | NORDAM Group Inc., Pays $2 Million Penalty to Settle FCPA Allegations
Eric Carlson, Shaoyu Chen, Timothy P. Stratford; Covington & Burling LLP;
Legal Alert/Article July 25, 2012, previously published on July 19, 2012 On July 17, 2012, NORDAM Group, Inc. (“NORDAM”), agreed to pay $2 million to settle charges by the US Department of Justice (“DOJ”) that NORDAM employees violated the US Foreign Corrupt Practices Act (“FCPA”) by making improper payments to employees of...
| | SFDA Issues Draft Regulations Blacklisting Violators of Certain Drug or Device Laws
Eric Carlson, Shaoyu Chen, Scott Cunningham, Yan Luo, Jason Ma; Covington & Burling LLP;
Legal Alert/Article June 20, 2012, previously published on June 14, 2012 On May 30, 2012, China’s State Food and Drug Administration ("SFDA") issued draft regulations entitled Provisions on the Administration of a Drug Safety Blacklist (“Proposed Provisions”) for public comment. If adopted, the Proposed Provisions would require SFDA to...
| | Biomet, Inc. Pays $22.88 Million to Settle FCPA Allegations
Eric Carlson, Shaoyu Chen, Timothy P. Stratford; Covington & Burling LLP;
Legal Alert/Article April 3, 2012, previously published on March 29, 2012 On March 26, 2012, Biomet, Inc. (“Biomet”) agreed to pay $22.88 million to settle allegations that Biomet employees and distributors made improper payments to publicly-employed health care providers in China, Argentina, and Brazil to sell products. According to a complaint filed by the...
| | Chinese Government Centralizes Database of Bribery Convictions
Eric Carlson, Shaoyu Chen, Timothy P. Stratford; Covington & Burling LLP;
Legal Alert/Article February 20, 2012, previously published on February 17, 2012 On February 16, 2012, China’s Supreme People’s Procuratorate (“SPP”), the main investigatory and prosecutorial arm of the Chinese government, in conjunction with other PRC anti-corruption agencies, announced that a database listing individuals and companies found guilty of...
| | China’s State Council Approves Draft Tender Regulations
Eric Carlson, Shaoyu Chen, Timothy P. Stratford; Covington & Burling LLP;
Legal Alert/Article December 16, 2011, previously published on December 8, 2011 On November 30, 2011, China’s State Council approved for internal review draft regulations on tendering (“the Draft Tender Regulations”). While the full text of the regulations has not yet been publicly released, an official announcement by the State Council (Chinese) and reports...
| | Chinese Pharmaceutical Companies Fined For Antitrust Violations
Shaoyu Chen, Paul M. Claydon, Scott Cunningham, John D. Graubert, James J. O'Connell, James C. Snipes, Timothy P. Stratford; Covington & Burling LLP;
Legal Alert/Article November 24, 2011, previously published on November 18, 2011 China’s National Development & Reform Commission (“NDRC”) announced this week that it has fined two domestic pharmaceutical companies for monopolizing bulk sales of promethazine hydrochloride in violation of the country’s Anti-Monopoly Law (“AML”). The...
| | Watts Water Pays $3.7 Million to Settle China-Related FCPA Allegations
Eric Carlson, Shaoyu Chen, Timothy P. Stratford; Covington & Burling LLP;
Legal Alert/Article October 21, 2011, previously published on October 18, 2011 On October 13, 2011, the US Securities and Exchange Commission (“SEC”) issued an administrative cease and desist order asserting violations of the Foreign Corrupt Practices Act (“FCPA”) to Watts Water Technologies, Inc. (“Watts”) and a former employee of one of...
|
|